The individual effect of GSTO1*C419A (rs4925), GSTO2*A424G (rs156697), and GSTO2*A183G (rs2297235) polymorphisms on the risk for testicular GCT development was assessed in order to establish risk-associated genotypes. Here, GSTO2 is linked to granular cell tumor.